Market Analysts see Esperion Therapeutics Inc [ESPR] gaining to $4. Time to buy?
Esperion Therapeutics Inc [NASDAQ: ESPR] slipped around -0.06 points on Wednesday, while shares priced at $1.89 at the close of the session, down -3.08%. Compared to the average trading volume of 6.28M shares, ESPR reached a trading volume of 4110455 in the most recent trading